COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,388 Articles (22,816 medRxiv, 8,572 bioRxiv)

Most recent first Previous |  Page 887: Articles 8861-8870  | Next

Safety and immunogenicity of SARS-CoV-2 vaccine MVC-COV1901 in adolescents in Taiwan: A double-blind, randomized, placebo-controlled phase 2 trial
Liu, L. T. C., Chiu, C.-H., Chiu, N.-C., Tan, B.-F., Lin, C.-Y., Cheng, H.-Y., Lin, M.-Y., Lien, C. E., Chen, C., Huang, L.-M.
10.1101/2022.03.14.22272325 — Posted: 2022-03-15
Employer Requirements and COVID-19 Vaccination and Attitudes among Healthcare Personnel in the U.S.: Findings from National Immunization Survey Adult COVID Module, August - September 2021
Lee, J. T., Hu, S., Zhou, T., Bonner, K., Kriss, J., Wilhelm, E., Carter, R., Holmes, C. B., De Perio, M. A., Lu, P.-J., Nguyen, K., Brewer, N. T., Singleton, J.
10.1101/2022.03.14.22271847 — Posted: 2022-03-15
Biomarkers Selection for Population Normalization in SARS-CoV-2 Wastewater-based Epidemiology
Hsu, S.-Y., Bayati, M. B., Li, C., Hsieh, H.-Y., Belenchia, A., Johnson, H., Klutts, J., Reynolds, M., Semkiw, E., Wenzel, J., Wieberg, C., Zemmer, S. A., Foley, T., Johnson, M., Lin, C.-H.
10.1101/2022.03.14.22272359 — Posted: 2022-03-15
Area-level social and structural inequalities determine mortality related to COVID-19 diagnosis in Ontario, Canada: a population-based explanatory modeling study of 11.8 million people
Wang, L., Calzavara, A., Baral, S., Smylie, J., Chan, A. K., Sander, B., Austin, P. C., Kwong, J. C., Mishra, S.
10.1101/2022.03.14.22272368 — Posted: 2022-03-15
Super-spreaders of novel coronaviruses that cause SARS, MERS and COVID-19 : A systematic review
Brainard, J. S., Jones, N. R., Harrison, F., Hammer, C. C., Lake, I. R.
10.1101/2022.03.14.22272351 — Posted: 2022-03-15
Pulmonary lesions following inoculation with the SARS-CoV-2 Omicron BA.1 (B.1.1.529) variant in Syrian golden hamsters
Rissmann, M., Noack, D., van Riel, D., Schmitz, K. S., de Vries, R. D., van Run, P., Lamers, M. M., GeurtsvanKessel, C., Koopmans, M., Fouchier, R., Kuiken, T., Haagmans, B., Rockx, B.
10.1101/2022.03.15.484448 — Posted: 2022-03-15
Immunogenicity of the third and fourth BNT162b2 mRNA COVID-19 boosters and factors associated with immune response in systemic lupus erythematosus and rheumatoid arthritis patients
Assawasaksakul, T., Sathitratanacheewin, S., Vichaiwattana, P., Wanlapakorn, N., Poovorawan, Y., Avihingsanon, Y., Assawasaksakul, N., Kittanamongkolchai, W.
10.1101/2022.03.15.22272350 — Posted: 2022-03-15
The impact of COVID-19 on pregnant and recently pregnant women in Malawi: A national facility-based cohort
Chapuma, C. I. J., Mndala, L., Gadama, L., Kachale, F., Likaka, A., Bilesi, R., Mbewe, M., Maseko, B., Ndamala, C., Makuluni, R., Kuyere, A., Munthali, L., Phiri, D., Masesa, C., Henrion, M. Y. R., Kumwenda, M., Lissauer, D.
10.1101/2022.03.15.22272348 — Posted: 2022-03-15
Neutrophils initiate the destruction of the olfactory epithelium during SARS-CoV-2 infection in hamsters
Bourgon, C., Saint-Albin-Deliot, A., Ando-Grard, O., Da-Costa, B., Domain, R., Korkmaz, B., Klonjkowski, B., Lepoder, S., Meunier, N.
10.1101/2022.03.15.484439 — Posted: 2022-03-15
Structural basis of Omicron immune evasion: A comparative computational study of Spike protein-Antibody interaction.
Contractor, D., Globisch, C., Swaroop, S., Jain, A.
10.1101/2022.03.15.484421 — Posted: 2022-03-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).